CClinicalTrials.gg
CompletedNCT07165054Updated Jan 30, 2026

Periodontal Pathogens and Atherom Plaque The Number of Mitochondrial DNA Copies

An observational study in Periodontal Inflammation, Biofilm and Endothelial Dysfunction, sponsored by Istanbul Saglik Bilimleri University. Completed at 1 site in Turkey (Türkiye). Open to participants aged 25 Years to 90 Years. Per ClinicalTrials.gov, last updated 2026-01-30.

Sponsored by Istanbul Saglik Bilimleri University · Observational

Study type
Observational
Model
Other
Time perspective
Cross-sectional
Enrollment
51
Ages
25 Years to 90 Years
Sex
All
01

Study summary

Periodontitis is a chronic inflammatory disease of the tooth-supporting tissues characterized by the constant interaction of microorganisms in subgingival plaque and host defense mechanisms. Periodontitis is considered a focus of infection caused by oral bacteria, bacterial byproducts, or inflammatory mediators that can interact with other parts of the body via the bloodstream.

Read the detailed description

Periodontitis is a chronic inflammatory disease of the tooth-supporting tissues characterized by the constant interaction of microorganisms in subgingival plaque and host defense mechanisms. Periodontitis is considered a focus of infection caused by oral bacteria, bacterial byproducts, or inflammatory mediators that can interact with other parts of the body via the bloodstream.

Periodontal bacteria produce endotoxins in the form of lipopolysaccharide (LPS). Circulating LPS reacts with Toll-like receptors, promoting the production of reactive oxygen species and phagocytosis in the intima layer. Oxidative stress has been reported to be associated with mtDNA copy number.

02

Conditions studied

  • Periodontal Inflammation
  • Biofilm
  • Endothelial Dysfunction
  • Oral Bacteria
03

In context

Lead sponsor

Istanbul Saglik Bilimleri University is the lead sponsor of 58 studies on the registry; 15 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
25 Years to 90 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Endearterectomy diagnosed, dentate and edentulous patients

Inclusion criteria

  • Diagnosed with endarterectomy
  • Not receiving chemotherapy
  • Not having received this treatment before

Exclusion criteria

Exclusion Criteria:

  • Having systemic infection
  • Patients with severe heart disease
05

Study design

Observational model
Other
Time perspective
Cross-sectional
Enrollment
51 participants (actual)
Patient registry
No

Groups and cohorts

  • Patients diagnosed with endarterectomy

    Other: atheroma plaque · Other: Dental plaque

Interventions

  • Otheratheroma plaque

    Before the endarterectomy procedure, samples will be collected for study from some of the atheroma plaques routinely taken for pathology from patients.

  • OtherDental plaque

    Subgingival plaque samples will be collected from patients before the endarterectomy procedure.

06

What researchers measure

Primary outcomes

  1. Bacterial frequency (%)

    The percentage of bacteria in the red complex in atheroma plaque and dental plaque is evaluated using polymerase chain reaction methods.

    Time frame: Months 6-9 of the study

Secondary outcomes

  1. Changes in mtDNA copy number (number)

    Evaluation by means of quantitative polymerase chain reaction of mtDNA copy number in atheroma plaque

    Time frame: Months 6-9 of the study

  2. periodontal healths (mm)

    Evaluation by means of periodontal indices such as PI, GI, BOP, PD.

    Time frame: 8 months

07

Study locations

1 site
  • Health Sciences University, Hamidiye Faculty of Dentistry, Department of Periodontology
    Istanbul, Turkey (Türkiye)
08

References and documents

Publications

  • Toraman A, Saglam E, Toraman E, Ketenciler S, Koseoglu S. Red-Complex Bacterial DNA in Carotid Atheroma of Dentate and Long-Term Edentulous Patients and Its Association With Mitochondrial DNA Copy Number. Oral Dis. 2026 Jul 16. doi: 10.1111/odi.70431. Online ahead of print. PubMed 42464421 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 30, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07165054
Lead sponsor
Istanbul Saglik Bilimleri University
Responsible party
Ayşe Toraman (associate professor, Istanbul Saglik Bilimleri University) — Principal investigator
First posted
Sep 10, 2025
Start date
Apr 10, 2025
Primary completion
Nov 1, 2025
Completion
Dec 1, 2025
Last update
Jan 30, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion